Evidence map›Paper›PMID 25955568›Full record

ArticleInternational journal of oncology2015

Characterization of glioma stem-like cells from human glioblastomas.

Shun Yamamuro, Yutaka Okamoto, Emiko Sano, Yushi Ochiai, Akiyoshi Ogino, Takashi Ohta, Hiroyuki Hara, Takuya Ueda, Tomohiro Nakayama, Atsuo Yoshino and 1 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of oncology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Tumor heterogeneity and resistance in glioblastoma: the role of stem cells.Apoptosis : an international journal on programmed cell death · 2025
    Review
  3. Article
  4. Review
  5. Review
  6. Electrotherapies for Glioblastoma.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2021
    Review
  7. Review
  8. Novel ablation methods for treatment of gliomas.Journal of neuroscience methods · 2020
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Shun YamamuroDepartment of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan.
Yutaka OkamotoNew Energy and Industrial Technology Development Organization, Kanagawa, Japan.
Emiko SanoDepartment of Medical Genome Sciences, Graduate School of Frontier Science, The University of Tokyo, Chiba, Japan.
Yushi OchiaiDepartment of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan.
Akiyoshi OginoDepartment of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan.
Takashi OhtaDepartment of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan.
Hiroyuki HaraDepartment of Functional Morphology, Nihon University School of Medicine, Tokyo, Japan.
Takuya UedaDepartment of Medical Genome Sciences, Graduate School of Frontier Science, The University of Tokyo, Chiba, Japan.
Tomohiro NakayamaDivision of Companion Diagnostics, Department of Pathology of Microbiology, Nihon University School of Medicine, Tokyo, Japan.
Atsuo YoshinoDepartment of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan.
Yoichi KatayamaDepartment of Neurological Surgery, Nihon University School of Medicine, Tokyo, Japan.
Nihon University · JPThe University of Tokyo · JPNew Energy and Industrial Technology Development Organization · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioma stem-like cells (GSCs) could have potential for tumorigenesis, treatment resistance, and tumor recurrence (GSC hypothesis). However, the mechanisms underlying such potential has remained elusive and few ultrastructural features of the cells have been reported in detail. We therefore undertook observations of the antigenic characteristics and ultrastructural features of GSCs isolated from human glioblastomas. Tumor spheres formed by variable numbers of cells, exhibiting a variable appearance in both their size and shape, were frequently seen in GSCs expressing the stem cell surface markers CD133 and CD15. Increased cell nucleus atypia, mitochondria, rough endoplasmic reticulum, coated vesicles, and microvilli, were noted in the GSCs. Furthermore, cells at division phases and different phases of the apoptotic process were occasionally observed. These findings could imply that GSCs have certain relations with human neural stem cells (NSCs) but are primitively different from undifferentiated NSCs. The data may provide support for the GSC hypothesis, and also facilitate the establishment of future glioblastoma treatments targeting GSCs.

Indexed as

AC133 AntigenAntigens, CDBrain NeoplasmsCell DifferentiationCell Line, TumorFucosyltransferasesGlioblastomaGlycoproteinsHumansLewis X AntigenNeoplastic Stem CellsNeural Stem CellsPeptidesSpheroids, CellularAC133 AntigenAntigens, CDFucosyltransferasesFUT4 protein, humanGlycoproteinsLewis X AntigenPeptidesPROM1 protein, human

Identifiers

PMID25955568
PMCPMC4485645
OpenAlexW1604741301

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.